Name None Company Speaker Bureau Consultant Research Travel Other support support ownership Attard Gerhardt Janssen >50K <10K >50K 10-50K Veridex <10K <10K <10K <10K Astellas <10K <10K <10K Medivation <10K 10-50K Novartis <10K Millenium Pharma <10K Abbot Labs <10K <10K Essa Pharma <10K 10-50K Healthcare <10K <10K Takeda <10K Sanofi-Aventis <10K AstraZeneca >50K Arno Therapeutics 10-50K Innocrin Pharma 10-50K Institute of Cancer 10-50K Reserach Rewards to Inventors for Abiraterone Beer Tomasz Astellas <10K >50K AstraZeneca <10K Bayer <10K BMS >50K Churchill <10K Dendreon <10K >50K Janssen <10K >50K Medivation >50K OncoGenex >50K Roche <10K Salarius No value Sotio >50K Beltran Himisha Millenium/Takeda >50K
Name None Company Speaker Bureau Consultant ownership Research support Travel support Other Attard Gerhardt Janssen Veridex Astellas Medivation Novartis Millenium Pharma Abbot Labs Essa Pharma Healthcare Takeda Sanofi-Aventis AstraZeneca Arno Therapeutics Innocrin Pharma Institute of Cancer Reserach Rewards to Inventors for Abiraterone >50K <10K <10K <10K <10K <10K <10K <10K <10K <10K <10K <10K <10K <10K <10K 10-50K >50K >50K 10-50K 10-50K 10-50K <10K <10K 10-50K <10K 10-50K <10K Beer Tomasz Astellas AstraZeneca Bayer BMS Churchill Dendreon Janssen Medivation OncoGenex Roche Salarius Sotio <10K <10K <10K <10K <10K <10K <10K No value >50K >50K >50K >50K >50K >50K >50K Beltran Himisha Millenium/Takeda >50K
1-s2.0-S0302283817304979-mmc4.docx